QVANTEQ
Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. Its bioactive Qstent controls in-growth therefore reducing the risk of restenosis and thrombosis. The company was awarded with the CTI start-up label in 2012. Qvanteq was founded in 2009 and is held by private investors. The ISO 13485 certified company is based in Zürich, Switzerland. It is a spin-off company from the Swiss Federal Institute of Technology, Zurich.
QVANTEQ
Social Links:
Industry:
Biotechnology Developer Platform Medical
Founded:
2009-01-01
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.qvanteq.com
Total Employee:
1+
Status:
Active
Contact:
41 44 500 98 90
Email Addresses:
[email protected]
Total Funding:
4.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache Wordpress Plugins Google Apps For Business
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Verve Ventures
Verve Ventures investment in Seed Round - Qvanteq
Venture Kick
Venture Kick investment in Grant - Qvanteq
Official Site Inspections
http://www.qvanteq.com
- Host name: sl262.web.hostpoint.ch
- IP address: 217.26.54.108
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "Qvanteq"
Qvanteq – | smart medical technology.
Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s medical devices and vascular stents. Qvanteq’s Qstent technology stands for reduced thrombus formation and fast healing. …See details»
Qvanteq - Crunchbase Company Profile & Funding
Qvanteq is a medtech startup company, developing novel bioactive stents to address and overcome the clinical adverse effects of today’s available coronary and endovascular stents. …See details»
Qvanteq AG - LinkedIn
Qvanteq’s Qstent technology stands for reduced thrombus formation and fast healing. Qvanteq AG was founded in early 2009 and is held by private investors. Qvanteq AG | 147 followers on …See details»
Qvanteq 2025 Company Profile: Valuation, Funding & Investors
Who are Qvanteq’s investors? Mende Family Office, Startup Invest, Verve Ventures, Venture Kick, and ETH Zurich have invested in Qvanteq. Data Transparency. Meet our data hygiene …See details»
Qvanteq - Headquarter Location, Corporate Office Address and …
Qvanteq is Surgical Devices in Switzerland that focus on based peripheral stents business. Founded in 2009. They cover business area such as developer, stent technology, coronary …See details»
Qvanteq - Contacts, Employees, Board Members, Advisors & Alumni
Qvanteq is a medtech startup company, developing surface technology that can be applied onto any coronary stent. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. …See details»
Qvanteq AG – Swiss Biotech
Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s vascular stents. ... Technoparkstrasse 1, 8005 Zürich, Switzerland. Get …See details»
BoD Title – Qvanteq
Dr. Armin W. Mäder, Chairman of the Board of directors & Co-Founder. Dr. Armin Mäder held senior positions in biotech and medtech companies such as Institut Straumann AG. He was the CFO/COO of the biotech start-up company AC …See details»
Qvanteq AG - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Qvanteq AG of Zürich, ZÜRICH. Get the latest business insights from Dun & Bradstreet.See details»
Qvanteq - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Qvanteq is a medtech startup company, developing surface technology that can be applied onto any coronary stent. New. Resources. ... Experience the new Crunchbase, powered by AI . …See details»
About us - Qvanteq
Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s medical devices and vascular stents. Qvanteq’s Qstent technology stands for …See details»
Qvanteq - Crunchbase
Qvanteq is a medtech startup company, developing surface technology that can be applied onto any coronary stent.See details»
Qvanteq AG - startup.ch
Qvanteq is ISO 13485 certified. It is a spin-off company from the Swiss Federal Institute of Technology (ETH) Zurich. The company was awarded with the CTI start-up label in 2012. …See details»
Qvanteq - Products, Competitors, Financials, Employees, …
Qvanteq’s bioactive Qstent promises fast and controlled healing therefore reducing the risk of restenosis (re-narrowing) and thrombosis. Benoit de Combaud, CombaGroup SA – Green …See details»
Investors - Qvanteq
Qvanteq AG has completed several financing rounds with private investors mainly. For inquiries please contact the company. Recent News. Reduced thrombogenicity of surface-treated …See details»
Qvanteq AG - Venturelab
Dec 1, 2009 Qvanteq is ISO 13485 certified. It is a spin-off company from the Swiss Federal Institute of Technology (ETH) Zurich. The company was awarded with the CTI start-up label in …See details»
Qvanteq is a Verve Ventures portfolio company
Qvanteq develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s medical devices and vascular stents. The Qstent technology is …See details»
Qvanteq - Updates, News, Events, Signals & Triggers - Crunchbase
Qvanteq is a medtech startup company, developing surface technology that can be applied onto any coronary stent. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. …See details»
Consulting – Qvanteq
Qvanteq provides general support for your development program. Based on our technical expertise as well as from our experience in developing a class III medical device (including …See details»
Contact – Qvanteq
Qvanteq AG Technoparkstrasse 1 CH-8005 Zürich Switzerland Phone +41 44 500 98 90. Email: [email protected]. UID: CHE-114.666.128. Public transportation timetable: Recent News. …See details»